Download App

Log in to access Online Inquiry
Company Overview More
New Horizon Health Ltd is a Chinese investment holding company mainly engaged in the R & D, clinical development, test operation and commercialization of colorectal cancer, gastric cancer and cervical cancer screening products. The company sells Chang Weiqing, Pupu and other products to customers through its own network, contract sales organization (CSO) and online or electronic platforms operated by medical clinics. The company's pylorus (a fecal-based self-test for gastric cancer screening test) and Gongzenqing (a non-invasive urine cervical cancer home screening test) are under development.
CEO: Yiyou Chen
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 06606 NH HEALTH-B > Detailed Quotes

06606 NH HEALTH-B

17.360+0.520+3.09%
Closed 05/20 16:08 CCT
High
17.500
Open
16.900
Turnover
12.52M
Low
16.840
Pre Close
16.840
Volume
724.50K
Market Cap
7.46B
P/E(TTM)
Loss
52wk High
89.650
Shares
429.74M
P/E(Static)
Loss
52wk Low
14.000
Float Cap
7.46B
Bid/Ask %
-57.42%
Historical High
89.650
Shs Float
429.74M
Volume Ratio
0.75
Historical Low
14.000
Dividend TTM
--
Div Yield TTM
--
P/B
2.87
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.17%
Amplitude
3.92%
Avg Price
17.278
Lot Size
500
Float Cap
7.46B
Bid/Ask %
-57.42%
Historical High
89.650
Shs Float
429.74M
Volume Ratio
0.75
Historical Low
14.000
Dividend TTM
--
P/B
2.87
Dividend LFY
--
Turnover Ratio
0.17%
Amplitude
3.92%
Avg Price
17.278
Lot Size
500
Price Forecast

No Data

News

Comment

No More